Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Pharmacopsychiatry|August 25, 2000
Acute stress induced modifications of calcium signaling in learned helpless ratsK Velbinger, J De Vry, K Jentzsch, et al.
Psychopharmacology|April 20, 1999
Calcium channel agonist (-)-BAY k 8644 suppresses free and limited access intake of alcohol in genetic drinking ratsM W West, T A Biggs, R Schreiber, et al.
Psychopharmacology|October 1, 1996
The calcium channel agonist BAY k 8644 reduces ethanol intake and preference in alcohol-preferring AA ratsR de Beun, R Schneider, A Klein, et al.
Journal of Cardiothoracic and Vascular Anesthesia|July 31, 2016
Moderate Aortic Valvular Insufficiency Invalidates Vortex Formation Time as an Index of Left Ventricular Filling Efficiency in Patients With Severe Degenerative Calcific Aortic Stenosis Undergoing Aortic Valve ReplacementPaul S Pagel, Brent T Boettcher, Derek J De Vry, et al.
Brain Research. Molecular Brain Research|November 14, 1998
Long-term alcohol self-administration and alcohol withdrawal differentially modulate microtubule-associated protein 2 (MAP2) gene expression in the rat brainJ Putzke, R De Beun, R Schreiber, et al.
Schmerz (Berlin, Germany)|January 25, 2011
[Tapentadol: with two mechanisms of action in one molecule effective against nociceptive and neuropathic pain. Preclinical overview]T M Tzschentke, T Christoph, W Schröder, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 2011
Synergistic interaction between the two mechanisms of action of tapentadol in analgesiaW Schröder, T M Tzschentke, R Terlinden, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?T Jolas, R Schreiber, A M Laporte, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 13, 1998
Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonistJ De Vry, R Schohe-Loop, H G Heine, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Discovery and optimization of 2-aryl oxazolo-pyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesisM Bauser, G Delapierre, M Hauswald, et al.
Pageof 8